|
The December STAR performers:
- Faritec - oscillating between 4 and 5 cents. The trading update implies a smaller loss for the 6 months to Dec09, so let's see if they can break even for the full year. They need to raise a further R 60 mln. Perhaps a share consolidation can somehow be done in conjunction with this raising.
- UCS - interesting that the share has reacted quite positively after a poor set of income statement numbers in the annuals to Sep. what appeared to be a average set of annual results recently. However there were strong cash flows and the dividend was maintained.
- GijimaAst - not surprising. We think it is still quite undervalued. Doing well in the public sector. Closed period share buyback is a positive.
- Net1 - the downtrend from R160 to R130 has reversed despite CEO Serge Belamant having sold 1 mln shares (half his holding) netting him around USD 18 mln.
- EOH - this quality counter continues its upward trend reaching almost R10. After the last annual results, we rated it a buy with a DCF value just above R13. Interesting that deputy CEO Lucky Khumalo has sold 1 mln shares for R 9.4 mln.
- SecureData - we re-iterate the good performance they had in their second half at their last annual results. Things are turning around. The share has risen by 44% over the past 3 months. Very low Dec volumes.
The December laggards:
- Vox Telecom - has been the worst laggard for three months in a row! 2 of those with very high volumes. At a price of 31 cents, we felt the market was unrealistically pricing in the end of the world for Vox. It looked as if their Orion LCR operations were being valued at zero. It doesn't surprise us to see that the share has shot up to 40c in the first few days of Jan.
- Simeka -the midpoint of their interim trading statement (HEPS down 40-50%) implies HEPS of 4.8c - below where we would have hoped. The share has fallen a lot, but we continue to believe it is very undervalued.
- Spescom - has given up some of the gains from being the best performer in November - albeit on low volumes. We are still waiting to hear what the cautionary is all about.
|